MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on October 20, 2004; DOI: 10.1124/mol.104.004200


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.004200v1
67/1/152    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, J.
Right arrow Articles by Wang, Q. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, J.
Right arrow Articles by Wang, Q. J.


Received for publication June 25, 2004.
Revised October 19, 2004.
Accepted for publication October 19, 2004.

Protein Kinase C-Independent Effects of Protein Kinase D3 in Glucose Transport in L6 Myotubes

Jun Chen 1, Ganwei Lu 1, Qiming Jane Wang 1*

1 University of Pittsburgh School of Medicine

* Address correspondence to: E-mail: qjw1{at}pitt.edu

Abstract

Protein kinase C (PKC) and protein kinase D (PKD) coordinate and regulate many fundamental cellular processes. In this study, we evaluate the role of classical and novel PKCs (c/nPKC) and PKD in glucose transport in L6 myotubes. c/nPKC is either activated by short-term PMA treatment or down-regulated by prolonged PMA treatment at high dose in L6 myotubes. Our results indicate that PMA treatments have little impact on basal and insulin- stimulated glucose uptake and on insulin-induced Akt activation. In contrast, the PKC inhibitors Go6976, Go6983, GF 109203X, and Ro 31-8220 block basal and insulin-stimulated glucose uptake, and their inhibitory effects persist upon down-regulation of c/nPKC by PMA, implying the presence of PKC-independent effecters in mediating their inhibition of glucose uptake. Go6976, the potent cPKC inhibitor that also effectively inhibits PKD, dose-dependently blocks basal glucose uptake in L6 myotubes, while Go6983, the non-selective PKC inhibitor that is ineffective for PKD, has little effect on basal glucose uptake, implying the involvement of PKD in this process. Most prominently, adenoviral gene expression of a dominant-negative PKD isoform PKD3 inhibits primarily basal glucose uptake and, to a small extent, insulin-stimulated glucose uptake, while overexpression of wild-type PKD3 significantly enhances basal glucose uptake. Moreover, expression of a PKD3-targeted siRNA significantly inhibits basal glucose uptake. Taken together, our results indicate that PKD, specifically PKD3, directly contributes to insulin-independent basal glucose uptake in L6 skeletal muscle cells.


Key words: Insulin, Protein Kinase C, Protein Kinases (other)


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
E. R. Sharlow, K. V. Giridhar, C. R. LaValle, J. Chen, S. Leimgruber, R. Barrett, K. Bravo-Altamirano, P. Wipf, J. S. Lazo, and Q. J. Wang
Potent and Selective Disruption of Protein Kinase D Functionality by a Benzoxoloazepinolone
J. Biol. Chem., November 28, 2008; 283(48): 33516 - 33526.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Chen, F. Deng, S. V. Singh, and Q. J. Wang
Protein Kinase D3 (PKD3) Contributes to Prostate Cancer Cell Growth and Survival Through a PKC{varepsilon}/PKD3 Pathway Downstream of Akt and ERK 1/2
Cancer Res., May 15, 2008; 68(10): 3844 - 3853.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Doppler and P. Storz
A Novel Tyrosine Phosphorylation Site in Protein Kinase D Contributes to Oxidative Stress-mediated Activation
J. Biol. Chem., November 2, 2007; 282(44): 31873 - 31881.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
P. M. Bhende, S. J. Dickerson, X. Sun, W.-H. Feng, and S. C. Kenney
X-Box-Binding Protein 1 Activates Lytic Epstein-Barr Virus Gene Expression in Combination with Protein Kinase D
J. Virol., July 15, 2007; 81(14): 7363 - 7370.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. M. Ivison, N. R. Graham, C. Q. Bernales, A. Kifayet, N. Ng, L. A. Shobab, and T. S. Steiner
Protein Kinase D Interaction with TLR5 Is Required for Inflammatory Signaling in Response to Bacterial Flagellin
J. Immunol., May 1, 2007; 178(9): 5735 - 5743.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Feng, M. Ren, and C. S. Rubin
Conserved Domains Subserve Novel Mechanisms and Functions in DKF-1, a Caenorhabditis elegans Protein Kinase D
J. Biol. Chem., June 30, 2006; 281(26): 17815 - 17826.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Feng, M. Ren, S.-L. Wu, D. H. Hall, and C. S. Rubin
Characterization of a Novel Protein Kinase D: CAENORHABDITIS ELEGANS DKF-1 IS ACTIVATED BY TRANSLOCATION-PHOSPHORYLATION AND REGULATES MOVEMENT AND GROWTH IN VIVO
J. Biol. Chem., June 30, 2006; 281(26): 17801 - 17814.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. A. Matthews, P. Liu, M. Spitaler, E. N. Olson, T. A. McKinsey, D. A. Cantrell, and A. M. Scharenberg
Essential Role for Protein Kinase D Family Kinases in the Regulation of Class II Histone Deacetylases in B Lymphocytes
Mol. Cell. Biol., February 15, 2006; 26(4): 1569 - 1577.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics